99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
83

Doreen Monks – The Emotional Journey of Alzheimer’s and Dementia (part 2)

In this episode of BrainStorm, host Meryl Comer continues explore the challenges of dementia diagnosis in her interview with Doreen Monks, a former neuroscience nurse

LISTEN NOW
82

Doreen Monks – The Emotional Journey of Alzheimer’s and Dementia (part 1)

What if your life and career were upended with a diagnosis of Alzheimer’s only to learn eight years later that the diagnosis was wrong?  In

LISTEN NOW
81

Tony Bennett's Daughters - Breaking Through the Silence of Alzheimer's

Learning about an Alzheimer’s diagnosis in your family is never easy. When you are an iconic music legend like Tony Bennet with legions of adoring

LISTEN NOW
80

George Vradenburg and the Global Impact of Alzheimer's (part 1)

Alzheimer’s is not just an aging issue, but a lifelong brain health challenge that has major global, economic, and societal implications. George Vradenburg, Chairman and

LISTEN NOW
79

Rudy Tanzi – Alzheimer’s Updates and Developments; What’s New? (part 2)

In this episode of BrainStorm host Meryl Comer continues her compelling interview with "Rockstar of Science" Dr. Rudy Tanzi, the pioneering Director of the Genetics

LISTEN NOW